PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- Status
- RECRUITING
- Phase
- PHASE2
Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens
- Status
- COMPLETED
- Phase
- PHASE2
[18F]FES PET/CT in Endocrine Refractory Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Overcoming Endocrine Resistance in Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Retroprospective Real Life Observatory of Eribulin
- Status
- COMPLETED
- Phase
- N/A
A Pilot Dose Escalation Trial of a Densified Chemotherapy Association of Docetaxel and Epirubicin Driven by Mathematical Modeling in Metastatic Breast Cancer Patients: The MODEL1 Study
- Status
- COMPLETED
- Phase
- PHASE1
Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fulvestrant as Maintenance Therapy After First-line Chemotherapy in HER2 - Postmenopausal MBC Patients
- Status
- UNKNOWN
- Phase
- PHASE3
A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Observation of Medical Treatments in MBC HER2-negative Patients
- Status
- UNKNOWN
- Phase
- N/A
Evaluation of Icotinib in Metastatic Triple-negative Breast Cancer After Second-line Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Study Evaluating Pyrotinib in Combination With Capecitabine In Patients With HER2 Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Detect V / CHEVENDO (Chemo vs. Endo)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of ASLAN001 in Combination With Capecitabine in MBC That Has Failed on Prior Trastuzumab
- Status
- COMPLETED
- Phase
- PHASE2
Prospective Study of VEGFR-2 /IL-8 Genetic Interaction in MBC Treated With Paclitaxel and Bevacizumab vs. Chemotherapy
- Status
- COMPLETED
- Phase
- N/A
A Multicenter Trial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE Inhibitors
- Status
- TERMINATED
- Phase
- PHASE2